Limiting hospice access for dementia patients is likely to increase overall health care costs at the end of life, according to recent research. During the past decade, Medicare beneficiaries with dementia who utilized hospice had lower overall health care costs than those who did not, according to the Health Affairs study. The findings provide a […]
The international biotechnology company Psyence Group has entered into a licensing agreement with Filament Heath Corp. to support development of palliative care drugs derived from natural psilocybin. The agreement gives Psyence an exclusive license to use Filament’s botanical drug candidate PEX010 in clinical trials, initially in the United Kingdom. Both companies are publicly traded on […]
A lack of nursing and medical education in hospice and palliative care creates an additional obstacle for providers trying to push back against industry-wide labor shortages. Not only are hospices competing with other health care sectors for new hires, but the vast majority of clinicians entering the workforce are unprepared to provide those services. Most […]
The lack of standardized quality measures for palliative care complicates efforts to expand access to those services. This means community-based palliative care providers have limited ways to benchmark their performance and further demonstrate their value. The growing need for this type of care has led providers and industry groups to pump up the volume of […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
